{
    "name": "taliglucerase alfa",
    "comment": "Rx",
    "other_names": [
        "Elelyso"
    ],
    "classes": [
        "Enzymes",
        "Metabolic"
    ],
    "source": "https://reference.medscape.com/drug/elelyso-taliglucerase-alfa-999744",
    "pregnancy": {
        "common": [
            "Insufficient data available on use in pregnant females to inform a drug-associated risk"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "When pregnant rats and rabbits were administered IV taliglucerase alfa at doses up to 5 times the recommended human dose, there was no evidence of embryofetal toxicity"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Women with Type 1 Gaucher disease have an increased risk of spontaneous abortion if disease symptoms are not treated and controlled preconception and during pregnancy",
                    "Pregnancy may exacerbate existing Type 1 Gaucher disease symptoms or result in new disease manifestations",
                    "Type 1 Gaucher disease manifestations may lead to adverse pregnancy outcomes, including hepatosplenomegaly which can interfere with the normal growth of a fetus and thrombocytopenia which can lead to increased bleeding and possible postpartum hemorrhage requiring transfusion"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on taliglucerase alfa in human milk, effects on breast fed infants, or effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Anaphylaxis reported; if anaphylaxis occurs, discontinue infusion immediately and initiate appropriate treatment",
                "Allergic and infusion reactions are common and include headache, chest pain or discomfort, asthenia, fatigue, urticaria, erythema, increased blood pressure, back pain, arthralgia, and flushing; if allergic or infusion reactions occur, decrease the infusion rate or temporarily stop the infusion; antihistamines and/or antipyretics may be administered; medical support should be readily available when taliglucerase alfa administered; observe patients closely for an appropriate period of time after administration; reactions have occurred up to 3 hr after the start of infusion",
                "Consider risks and benefits of re-administering taliglucerase alfa in patients who have experienced severe reaction associated with taliglucerase alfa; use caution upon rechallenge; appropriate medical support should be readily available",
                "As with all therapeutic proteins, development of IgG anti-drug antibodies (ADA) has been reported (53%); unknown if presence of ADA is associated with higher risk of infusion reactions or immunogenicity",
                "Monitor patients that have had an immune response to other enzyme replacement therapies or who are switching to taliglucerase alfa; unknown if these patients are at higher risk of infusion reactions",
                "Dizziness and fatigue reported; caution patients against performing dangerous tasks that require mental alertness, including driving heavy machinery"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "19"
        },
        {
            "name": "Arthralgia",
            "percent": "13"
        },
        {
            "name": "Vomiting",
            "percent": "10"
        },
        {
            "name": "Arthralgia",
            "percent": "13"
        },
        {
            "name": "Headache",
            "percent": "13"
        },
        {
            "name": "Fatigue",
            "percent": "9"
        },
        {
            "name": "Nausea",
            "percent": "9"
        },
        {
            "name": "Dizziness",
            "percent": "9"
        },
        {
            "name": "Abdominal pain",
            "percent": "6"
        },
        {
            "name": "Pruritus",
            "percent": "6"
        },
        {
            "name": "Flushing",
            "percent": "6"
        },
        {
            "name": "Vomiting",
            "percent": "6"
        },
        {
            "name": "Urticaria",
            "percent": "6"
        },
        {
            "name": "Pain in extremity",
            "percent": "10"
        }
    ]
}